The pivotal application of patient-derived organoid biobanks for personalized treatment of gastrointestinal cancers

The pivotal application of patient-derived organoid biobanks for personalized treatment of gastrointestinal cancers

Abstract Gastrointestinal cancers (GICs) occupy more than 30% of the cancer-related incidence and mortality around the world. Despite advances in the treatment strategies, the long-term overall survival has not been improved for patients with GICs. Recently, the novel patient-derived organoid (PDO)...

Full description

Bibliographic Details
Main Authors: Ya-ya Yu, Yan-juan Zhu, Zhen-zhen Xiao, Ya-dong Chen, Xue-song Chang, Yi-hong Liu, Qing Tang, Hai-bo Zhang
Format: Article
Language:English
Published: BMC 2022-10-01
Series:Biomarker Research
Subjects:
Gastrointestinal cancers
Patient-derived tumor organoids
Biobanking
Personalized anti-cancer therapy
Online Access:https://doi.org/10.1186/s40364-022-00421-0

Internet

https://doi.org/10.1186/s40364-022-00421-0

Similar Items